Genetic and nongenetic sources of variation in phospholipid transfer protein activity

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 983-990

  Jarvik, Gail P ^a,b   Rajagopalan, Ramakrishnan ^a   Rosenthal, Elisabeth A ^a   Wolfbauer, Gertrud ^a   McKinstry, Laura ^a   Vaze, Aditya ^a   Brunzell, John ^a   Motulsky, Arno G ^a   Nickerson, Deborah A ^b   Heagerty, Patrick J ^b   Wijsman, Ellen M ^a,b   Albers, John J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Lipids; Polymorphism

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; CAROTID ARTERY DISEASE; CAUCASIAN; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERY DISEASES; CHILD; COHORT STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77951034342     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M000125     Document Type: Article

References (47)

1. Laffitte, B. A., S. B. Joseph, M. Chen, A. Castrillo, J. Repa, D. Wilpitz, D. Mangelsdorf, and P. Tontonoz. 2003. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 23: 2182-2191.
2. Tall, A. R., S. Krumholz, T. Olivecrona, and R. J. Deckelbaum. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J. Lipid Res. 26: 842-851.
3. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602. (Pubitemid 19030527)
4. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
5. Lie, J., R. de Crom, T. van Gent, R. van Haperen, L. Scheek, F. Sadeghi-Niaraki, and A. van Tol. 2004. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J. Lipid Res. 45: 805-811. (Pubitemid 38552850)
6. Moerland, M., H. Samyn, T. van Gent, R. van Haperen, G. Dallinga- Thie, F. Grosveld, A. van Tol, and R. de Crom. 2008. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28: 1277-1282.
7. Samyn, H., M. Moerland, T. van Gent, R. van Haperen, F. Grosveld, A. van Tol, and R. de Crom. 2009. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. Atherosclerosis. 204: 429-434.
8. van Haperen, R., H. Samyn, T. van Gent, A. J. Zonneveld, M. Moerland, F. Grosveld, H. Jansen, G. M. Dallinga-Thie, A. van Tol, and R. de Crom. 2009. Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism. Biochim Biophys Acta. 1791: 1031-1036
9. Liu, R., J. Iqbal, C. Yeang, D. Q. Wang, M. M. Hussain, and X. C. Jiang. 2007. Phospholipid transfer protein-deficient mice absorb less cholesterol. Arterioscler. Thromb. Vasc. Biol. 27: 2014-2021.
10. Vikstedt, R., D. Ye, J. Metso, R. B. Hildebrand, T. J. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 27: 578-586.
11. Valenta, D. T., J. J. Bulgrien, D. J. Bonnet, and L. K. Curtiss. 2008. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency. J. Lipid Res. 49: 24-32.
12. Tu, A-Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
13. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
14. Albers, J. J., J. G. Wolfbauer, M. C. Cheung, J. R. Day, A. F. T. Ching, S. Lok, and A-Y. Tu. 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
15. Murdoch, S. J., M. C. Carr, J. E. Hokanson, J. D. Brunzell, and J. J. Albers. 2000. PLTP activity in premenopausal women: relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J. Lipid Res. 41: 237-244.
16. Murdoch, S. J., M. C. Carr, H. Kennedy, J. D. Brunzell, and J. J. Albers. 2002. Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J. Lipid Res. 43: 1256-1263.
17. Cheung, M. C., G. Wolfbauer, H. Deguchi, J. A. Fernandez, J. H. Griffin, and J. J. Albers. 2009. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. Biochim. Biophys. Acta. 1791: 206-211.
18. Schlitt, A., C. Bickel, P. Thumma, S. Blankenberg, H. J. Rupprecht, J. Meyer, and X. C. Jiang. 2003. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23: 1857-1862.
19. Cavusoglu, E., J. D. Marmur, S. Chhabra, V. Chopra, C. Eng, and X. C. Jiang. 2009. Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. Atherosclerosis. 207: 261-265
20. Schlitt, A., S. Blankenberg, C. Bickel, K. J. Lackner, G. H. Heine, M. Buerke, K. Werdan, L. Maegdefessel, U. Raaz, H. J. Rupprecht, et al. 2009. PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study. J. Lipid Res. 50: 723-729.
21. Schgoer, W., T. Mueller, M. Jauhiainen, A. Wehinger, R. Gander, I. Tancevski, K. Salzmann, P. Eller, A. Ritsch, M. Haltmayer, et al. 2008. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis. 196: 219-226.
22. de Vries, R., G. M. Dallinga-Thie, A. J. Smit, B. H. Wolffenbuttel, A. van Tol, and R. P. Dullaart. 2006. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia. 49: 398-404. (Pubitemid 43185411)
23. O'Brien, K. D., S. Vuletic, T. O. McDonald, G. Wolfbauer, K. Lewis, A. Y. Tu, S. Marcovina, T. N. Wight, A. Chait, and J. J. Albers. 2003. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation. 108: 270-274. (Pubitemid 36899015)
24. Desrumaux, C. M., P. A. Mak, W. A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L. K. Curtiss. 2003. Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. J. Lipid Res. 44: 1453-1461. (Pubitemid 37279589)
25. Kathiresan, S., B. F. Voight, S. Purcell, K. Musunuru, D. Ardissino, P. M. Mannucci, S. Anand, J. C. Engert, N. J. Samani, H. Schunkert, et al. 2009. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41: 334-341.
26. Engler, M. B., C. R. Pullinger, M. J. Malloy, Y. Natanzon, M. V. Kulkarni, J. Song, C. Eng, J. Huuskonen, C. Rivera, A. Poon, et al. 2008. Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. Metabolism. 57: 1719-1724.
27. Crawford, D. C., A. S. Nord, M. D. Badzioch, J. Ranchalis, L. A. McKinstry, M. Ahearn, C. Bertucci, C. Shephard, M. Wong, M. J. Rieder, et al. 2008. A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk. J. Lipid Res. 49: 588-596.
28. Pritchard, J. K., M. Stephens, and P. Donnelly. 2000. Inference of population structure using multilocus genotype data. Genetics. 155: 945-959.
29. Badzioch, M. D., R. P. Igo, Jr., F. Gagnon, J. D. Brunzell, R. M. Krauss, A. G. Motulsky, E. M. Wijsman, and G. P. Jarvik. 2004. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler. Thromb. Vasc. Biol. 24: 1942-1950.
30. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
31. Tishkoff, S. A., E. Dietzsch, W. Speed, A. J. Pakstis, J. R. Kidd, K. Cheung, B. Bonne-Tamir, A. S. Santachiara-Benerecetti, P. Moral, and M. Krings. 1996a. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science. 271: 1380-1387. (Pubitemid 26089471)
32. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
33. Jarvik, G. P., L. S. Rozek, V. H. Brophy, T. S. Hatsukami, R. J. Richter, G. D. Schellenberg, and C. E. Furlong. 2000. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler. Thromb. Vasc. Biol. 20: 2441-2447.
34. Tu, A. Y., and J. J. Albers. 2001. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes. 50: 1851-1856.
35. Durbin, J., and G. S. Watson. 1950. Testing for serial correlation in least squares regression. I. Biometrika. 37: 409-428.
36. Tregouet, D. A., P. Ducimetiere, and L. Tiret. 1997. Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am. J. Hum. Genet. 61: 189-199.
37. Servin, B., and M. Stephens. 2007. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3: e114.
38. Guan, Y., and M. Stephens. 2008. Practical issues in imputation-based association mapping. PLoS Genet. 4: e1000279.
39. Dullaart, R. P. F., W. J. Sluiter, L. D. Dikkeschei, K. Hoogenberg, and A. van Tol. 1994. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24: 188-194.
40. Riemens, S., A. van Tol, W. Sluiter, and R. Dullaart. 1998. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apo-lipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis. 140: 71-79. (Pubitemid 28378456)
41. Colhoun, H. M., M. R. Taskinen, J. D. Otvos, P. Van Den Berg, J. O'Conner, and A. van Tol. 2002. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes. Diabetes. 51: 3300-3305.
42. van Tol, A., J. J. M. Ligtenberg, S. C. Riemens, T. W. Van Haeften, W. D. Reitsma, and R. P. F. Dullaart. 1997. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand. J. Clin. Lab. Invest. 57: 147-158.
43. Cheung, M. C., B. G. Brown, E. K. Marino Larsen, A. D. Frutkin, K. D. O'Brien, and J. J. Albers. 2006. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim. Biophys. Acta. 1762: 131-137.
44. Urizar, N. L., D. H. Dowhan, and D. D. Moore. 2000. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275: 39313-39317.
45. Cao, G., T. P. Beyer, X. P. Yang, R. J. Schmidt, Y. Zhang, W. R. Bensch, R. F. Kauffman, H. Gao, T. P. Ryan, Y. Liang, et al. 2002. Phospholipid transfer protein is regulated by liver X receptors in vivo. J. Biol. Chem. 277: 39561-39565.
46. Tu, A. Y., and J. J. Albers. 1999. DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem. Biophys. Res. Commun. 264: 802-807.
47. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.